SCHEMBL4395822

OC[C@H]1O[C@@H](Oc2cccc(-c3c4nc(c(-c5cccc(O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5)c5ccc([nH]5)c(-c5cccc(O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5)c5nc(c(-c6cccc(O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)c6)c6ccc3[nH]6)CC5)C=C4)c2)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.48

Predicted protein targets (top 4)

	gene	UniProt	supporting neighbours	confidence
▸	TYR	P14679	3/20	0.41

▸	ATM	Q13315	1/20	0.38

▸	SLC5A2	P31639	1/20	0.38

▸	POLB	P06746	1/20	0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL14181422	0.97	TYR (0.40)	TYRATMSLC5A2
SCHEMBL14181421	0.97	TYR (0.40)	TYRATMSLC5A2
SCHEMBL14181424	0.97	TYR (0.40)	TYRATMSLC5A2
SCHEMBL4383594	0.94	TYR (0.45)	TYRATMSLC5A2POLB
SCHEMBL5349781	0.94	TYR (0.45)	TYRATMSLC5A2POLB
SCHEMBL24218341	0.94	TYR (0.46)	TYRATMSLC5A2POLB
SCHEMBL22111092	0.94	TYR (0.46)	TYRATMSLC5A2POLB
SCHEMBL14181423	0.92	TYR (0.36)	TYRATMSLC5A2
SCHEMBL22111051	0.91	TYR (0.44)	TYRATMSLC5A2
SCHEMBL24218354	0.91	TYR (0.44)	TYRATMSLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20090318370-A1	NOVEL GLYCOCONJUGATED CHLORIN DERIVATIVES AND METHOD OF PRODUCING THE SAME	REI MEDICAL CO., LTD.	2009-12-24	—	—	US	disclosed
US-20090318370-A1	NOVEL GLYCOCONJUGATED CHLORIN DERIVATIVES AND METHOD OF PRODUCING THE SAME	REI MEDICAL CO., LTD.	2009-12-24	—	—	US	disclosed
EP-2123664-A1	NOVEL SUGAR-LINKED CHLORIN DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF	Rei Medical Co., Ltd. (JP)	2009-11-25	—	—	EP	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20090318370-A1	NOVEL GLYCOCONJUGATED CHLORIN DERIVATIVES AND METHOD OF PRODUCING THE SAME	FUT6, ST6GAL1, CD2	TYR 45/4885ATM 2766/4885SLC5A2 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.